Farmaceuticos Comunitarios最新文献

{"title":"[Community pharmacy and global warming].","authors":"G Estrada Riolobos","doi":"10.33620/FC.2173-9218.(2025).15","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).15","url":null,"abstract":"<p><p>The acceleration of climate change due to human activities demands urgent action at all levels. In the healthcare sector, the use of inhalers with high global warming potential represents a significant source of emissions, further exacerbated by low recycling rates. The transition to lower-impact devices and improved waste management are priority actions. In this context, community pharmacists play a key role-not only in optimizing inhalation therapy and educating patients, but also in reducing the associated carbon footprint-thus promoting a more sustainable healthcare practice.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"1-2"},"PeriodicalIF":0.6,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12016044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144049231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Comprehensive Analysis of Compounded Prescription Orders: Types of Errors and Variability Among Autonomous Communities in Spain].","authors":"P Espáriz de la Cruz","doi":"10.33620/FC.2173-9218.(2025).14","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).14","url":null,"abstract":"<p><strong>Introduction: </strong>Compounding (FM) is a drug prepared according to the specific needs of a patient, under medical prescription, when the marketed medicines are not adequate according to the patient's pathology. This is why the FM is the last link in the Health System, in which the prescription is one of the critical elements of the FM preparation process. This study analyzes the distribution of FM, the most frequent errors and if there is any relation between the format used and the errors detected or where has it been prescribed.</p><p><strong>Methodology: </strong>Human compounding prescriptions which were obtained from a third party manufacturing pharmacy from the 1st of September until the 30th of November of 2023. All mandatory data from RD 1718/2010 of 17th of December was collected, as well as the specialty of the drug, where has been prescribed and what the format used is. On these prescriptions, a descriptive analysis will be carried out as well as an analysis of the absence of legally mandatory data.</p><p><strong>Results: </strong>a total of 6694 compounding prescriptions have been obtained, being the most frequent the ones from Madrid (4050), Castilla la Mancha (CLM) (1132) and Castilla y Léon (CyL) (1047) as the most common places of prescription.The most common format is paper (56,3 %), in which a lesser incidence of errors is observed in this format (5,9 (σ=2,889 SE=0,047)) rather than in electronic format (9,52 (σ=2,151 SE= 0,04)). On the other hand, significant difference were found among the number of errors per prescription and Autonomous Community (CCAA) (ANOVA p>0,001) and the number of errors per prescription and the format used (ANOVA p>0,001).</p><p><strong>Discussion: </strong>The largest number of prescriptions come from Madrid, CLM and CyL, with a notable frequency of ophthalmology and dermatology prescriptions. The most commonly used format is paper in the public and private spheres, with the exception of the Madrid Health System, where electronic formats predominate. It is noteworthy that electronic formats have a much higher error rate than paper formats, posing a potential risk for the preparation of the prescription.</p><p><strong>Conclusion: </strong>The results of frequency distribution by medical specialty may not be extrapolated due to overestimation of sterile pharmaceutical forms; however, format used and errors can be extrapolated.Despite what might be expected, electronic prescriptions are not the most commonly used format, possibly because they present a higher rate of errors per prescription. This higher rate can be caused by an incomplete prescription, deficient communication between the prescription system and the program used in pharmacies to access to this prescription or not knowing how to access the prescription data.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"48-59"},"PeriodicalIF":0.6,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144016875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Study of anticholinergic burden in chronic treatments of outpatients in the Community Pharmacy].","authors":"R Zaragoza Noguera, A Ballester Montilla, B Somoza Hernández","doi":"10.33620/FC.2173-9218.(2025).12","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).12","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Abstract: &lt;/strong&gt;The current aging of the population leads to an increase in morbidity and mortality, especially due to the higher incidence of chronic diseases and the need for associated polymedication. Among the drugs that are usually used to treat the most common pathologies in elderly patients, there are a large number of drugs with anticholinergic activity, which translates into anticholinergic effects, adverse effects that, although they can appear at any age, are especially significant in older patients, in whom the associated clinical consequences are important.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To analyze the use of anticholinergic activity drugs in outpatients, anticholinergic adverse effects and the anticholinergic burden associated with the chronic treatment of such patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A descriptive, observational, cross-sectional study was carried out in polymedicated patients who came to the pharmacy to pick up their medication, which included at least one drug with AA. The anticholinergic burden was calculated with the online application \"ACB calculator\", using the anticholinergic load value given by the ARS, ADS, ACB and DBI scales.The association between anticholinergic burden and adverse effects manifested in the last six months, the pathologies present, the pharmacological groups used and the number of prescribed drugs with anticholinergic activity were analyzed. In the statistical analysis, the \"Spearman's Rho\" correlation coefficient was used to study the correlation between the different variables, and the non-parametric \"Mann-Whitney U\" test was used to study the relationship between anticholinergic adverse effects and anticholinergic burden. The level of statistical significance was set at p&lt;0.05.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 44 patients were analyzed, with a mean age of 73.36 ± 12.34 years, of which 77.3% were women. The most frequent anticholinergic adverse effects were, at peripheral level dry mouth and constipation (54.5% and 38.6% respectively), and at central level dizziness and memory loss (31.8% and 40.9%, respectively). The patients took an average of 10.86 ± 3.88 drugs daily, of which 34% had anticholinergic activity. The drugs most frequently used by the patients were tramadol (27.2%) and lorazepam (34.1%). Statistically significant correlations were obtained between: i) the number of central anticholinergic adverse effects using the ARS (P=0.009, CI:0.097-0.622) and ADS (P=0.017, CI:0.061-0.872) scales, ii) the Drug Burden Index (DBI) and the number of prescribed drugswith anticholinergic activity (P&lt;0.001, CI:0.558-0.851), iii) the DBI index and drugs in the groups N02 (analgesics) (P&lt;0.001, CI:0.279-0.724), N06 (psychoanaleptics) and N06A (antidepressants) with the ARS scale (P&lt;0.001, CI:0.416-0.791; P&lt;0.001, CI:0.345-0.757, respectively).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The population studied is exposed to a high number of drugs with anticholinergic acti","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"30-43"},"PeriodicalIF":0.6,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12032187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143990208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Monitoring and nutritional advice for weight loss in patients under lithium treatment. A case report].","authors":"A M Mateos-Lardiés","doi":"10.33620/FC.2173-9218.(2025).13","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).13","url":null,"abstract":"<p><strong>Case presentation: </strong>A 44-year-old man patient, under lithium treatment, goes to the community pharmacy requesting nutritional advice for weight loss.</p><p><strong>Study and evaluation of the case: </strong>Poor dietary habits and lack of physical activity may have contributed to the patient's weight. Lithium concentration may be affected by changes in salt intake in patients receiving lithium treatment.</p><p><strong>Intervention: </strong>After contacting the psychiatrist, periodic pharmaceutical consultations were scheduled. Anthropometric values and blood pressure were recorded, the presence or absence of lithium intoxication symptoms was monitored, and guidelines for a balanced diet based on the Mediterranean Diet were provided, emphasizing the avoidance of changes in sodium intake. Physical activity was also recommended.</p><p><strong>Results: </strong>A weight loss of approximately 10% of the initial body weight was achieved, transitioning from the obesity category to the overweight category according to WHO classifications. The patient reported an increase in physical activity, and no signs of lithium intoxication were detected during any of the visits.</p><p><strong>Conclusions: </strong>The community pharmacist intervention contributed to a safe reduction in the patient's body weight. The community pharmacist is a professional to be considered in the nutritional and lifestyle management of patients.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"44-47"},"PeriodicalIF":0.6,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144037796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Good dispensing practices for antibiotics in community pharmacies of the province of Córdoba (Argentina)].","authors":"P Armando, M Moscardó, M I Tenllado","doi":"10.33620/FC.2173-9218.(2025).09","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).09","url":null,"abstract":"<p><strong>Objective: </strong>To develop a Good Dispensing Practices (GDP) Program for antibiotics (ATB) of greater demand in community pharmacies in the province of Córdoba (Argentina), to help reduce the antibiotic resistance (AR) and improve patients' knowledge about the need for prescription and proper use.</p><p><strong>Methods: </strong>A standard operating procedure (SOP) was designed on GDP for ATB. Subsequently, a training program for community pharmacists was designed and implemented through a virtual platform. At the end, the pharmacists registered the requests for ATB with the highest demand and carried out the corresponding interventions. Patient adherence and satisfaction with the service provided were analysed using validated tests.</p><p><strong>Results: </strong>A SOP on GDP for ATB was developed and validated. Subsequently, 278 pharmacists were trained, of which 208 joined the project. 2217 records of ATB requests were obtained, 68.1% corresponding to requests with prescription. The percentage of adherence to treatment was 57.3% and an average of 4.2 ± 0.7 was obtained in patient satisfaction (on a scale of 1 to 5).</p><p><strong>Conclusions: </strong>It is necessary to implement this SOP on a large scale for patient care, encouraging the role of the pharmacist to provide adequate information and improve adherence, with the aim of transforming the global threat of AR and maintaining the efficacy of current treatments.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"30-43"},"PeriodicalIF":0.6,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144040258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Inhaled Respiratory Therapy and Global Warming].","authors":"C Casanova-Martínez, E Espino-Paisán, L Buján-de-Gonzalo, M Lema-Oreiro, M J Álvarez-Sánchez","doi":"10.33620/FC.2173-9218.(2025).11","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).11","url":null,"abstract":"<p><strong>Introduction: </strong>Hydrofluorocarbon (HFC) propellants used in current pressurized metered-dose inhalers (pMDIs) act as potent greenhouse gases, contributing to global warming. The objective of this study is to analyse the type and pattern of use of inhaler use in the Galician population, as well as to assess its impact on the carbon footprint.</p><p><strong>Methodology: </strong>This is an observational, descriptive, and retrospective study conducted in the autonomous community of Galicia in 2023. It included patients receiving pharmaceutical care from the Galician Health Service (SERGAS) who are being treated with bronchial inhalers for the management of their respiratory conditions.</p><p><strong>Results: </strong>A total of 1.711.344 inhaler units were dispensed, equivalent to a carbon footprint of 15.247.142 kg CO2eq. pMDIs accounted for 43,17% (738.707) of the units dispensed in 2023, corresponding to almost 95,43% of the carbon footprint emitted by inhalers, with HFA-134a being the most used propellant (669.907 units).</p><p><strong>Conclusions: </strong>pMDIs contribute to global warming, generating nearly the entire carbon footprint emitted by inhalers used in respiratory therapy. SERGAS has implemented several strategies to reduce the environmental impact caused by pMDIs.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"21-29"},"PeriodicalIF":0.6,"publicationDate":"2025-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Adherence Improvement in Transplant Patient after Being Included in Medication Reconditioning Service].","authors":"M E Sánchez-Calero, D Pérez-Sánchez","doi":"10.33620/FC.2173-9218.(2025).10","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).10","url":null,"abstract":"<p><p>Male patient, 75 years of age, pluripathological and polymedicated. He underwent a liver transplant in 2006 so he was followed up by two hospitals in different provinces (Madrid and Castilla-La Mancha) which made the review even more difficult. the last few months, the pharmacists have noticed various discrepancies when dispensing his electronic prescriptions. We decided to offer him the Monitored Dosage Systems (MDS). He is a vulnerable patient given his pathologies and meets all the requirements to include him in the program.In a first interview, the patient is confused with the medication, he brings us full boxes of some medications and others are missing, suspecting that he does not follow the dosage indicated by the doctor, with the consequent lack of adherence to treatment.After the medication review, we found different Drug-Related Problems (DRPs): duplicity and dosage, regimen and/or inadequate duration. We contacted the primary care physician (GP) and the gastroenterologist to review the prescribed medication.After 8 months of being included in the MDS service, there has been a positive impact on the patient. He's health has significantly improved; he has gained weight, decreased the number of medication and improved his therapeutic adherence.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"15-20"},"PeriodicalIF":0.6,"publicationDate":"2025-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144055568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications].","authors":"F Alves Da Costa, F Fernandez-Llimos, S Desselle, I Arnet, Z Babar, Ch Bond, M Cordina, V Garcia Cardenas, M El Hajj, R Jacobsen, A W Law, L S Nørgaard, C Polidori, N Shcherbakova, D Stewart, F S Tonin, A E Weidmann","doi":"10.33620/FC.2173-9218.(2025).08","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2025).08","url":null,"abstract":"<p><strong>Resumen: </strong>The Granada statements were a result of the need to strengthen clinical, social and administrative pharmacy practice as an area of knowledge that translates into practice, research and policy. As a re-sponse, a group of clinical and social pharmacy practice journal editors launched an initiative in Grana-da in 2022 to discuss ways to improve the quality of publications in this area, which culminated in the Granada statements. Eighteen statements were developed, clustered into six main domains:1) the ap-propriate use of terminology; 2) developing impactful abstracts; 3) having the required peer reviews; 4) preventing journal scattering; 5) more effective and wiser use of journal and article performance met-rics; and 6) authors' selection of the most appropriate pharmacy practice journal to submit their work.The full Granada statements have been published in 14 journals.(1-14) These pioneering statements are rooted in similar endeavors undertaken by scholars in other health professions groups, fostering the concept of interdisciplinary consensus and advancing scientific paradigm.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 2","pages":"5-10"},"PeriodicalIF":0.6,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12020980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144020477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[SEFAC 2025 Conference: Community pharmacy facing the challenge of specialisation and change].","authors":"Leire Andraca, José Luis Allué","doi":"10.33620/FC.2173-9218.(2025).01","DOIUrl":"10.33620/FC.2173-9218.(2025).01","url":null,"abstract":"<p><p>In 2025, which marks the 25th anniversary of our scientific society, SEFAC will be celebrating its national conference under the slogan 'Community pharmacy as a health, scientific and specialised profession', which attempts to encapsulate the essence of this period of transformation for the profession. Embracing change is not just an option but a necessity to ensure a solid and recognised future. As part of the 15th Conference, the professional debate 'Speciality in community pharmacy: a necessity?' will be held, which will serve to reflect on the path towards the consolidation of a specialisation that legitimises and further enhances the role of the community pharmacist within the healthcare system.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 1","pages":"3-4"},"PeriodicalIF":0.6,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Impact of Ambulatory Blood Pressure Monitoring on patient health in remote areas: the role of Community Pharmacy].","authors":"Cristina Díaz-Jiménez","doi":"10.33620/FC.2173-9218.(2025).07","DOIUrl":"10.33620/FC.2173-9218.(2025).07","url":null,"abstract":"<p><strong>Introduction: </strong>Cardiovascular disease remains the leading cause of death. Arterial hypertension is the main avoidable risk factor. Scientific societies advise control methods such as Ambulatory Blood Pressure Monitoring (ABPM) but this technique is not usually available in rural settings.The aim of this study was to evaluate the effectiveness of pharmaceutical intervention using ABPM in community pharmacies.</p><p><strong>Material and method: </strong>Observational study conducted in a rural community pharmacy between July 2021 and December 2023. Patients over 18 years of age who were normotensive or had a previous diagnosis of hypertension were selected. They were fitted with a MicrolifeWatch BP03 device for 29 hours. Patients with results compatible with HT were referred to their primary care physician.</p><p><strong>Results: </strong>Twenty-one patients were included, of whom 20 were referred to the physician and treatment adjustments were made. Patient satisfaction was high, highlighting the accessibility of the service in the community pharmacy.</p><p><strong>Conclusion: </strong>The accessibility and proximity of community pharmacies, especially in rural areas, facilitates the application of MAPA, improving the control of HTN.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"17 1","pages":"40-44"},"PeriodicalIF":0.6,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}